Moderna is developing three new mRNA-based vaccines for seasonal flu, HIV and Nipah virus https://t.co/9cITn4YUHW #venturecapital #startups
— Renaissance Venture Capital (@renvcf) January 18, 2021
Programmable genetics gets more cash as Tessera Therapeutics gets a $230 million infusion https://t.co/PlT4AxwDaN #venturecapital #startups
— Renaissance Venture Capital (@renvcf) January 16, 2021
Ann Arbor biotech firm Evoq inks deal worth up to $240 million with drugmaker Amgen https://t.co/u0d7RvTrRE #venturecapital #startups
— Renaissance Venture Capital (@renvcf) January 14, 2021
Calling all Houston founders! The Venture Houston 2021 pitch competition has over $1.6M in investment, cash, & in-k… https://t.co/mMxmqWqniw
— Renaissance Venture Capital (@renvcf) January 13, 2021